These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 14687592

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mechanisms of ascites formation.
    Cárdenas A, Bataller R, Arroyo V.
    Clin Liver Dis; 2000 May; 4(2):447-65. PubMed ID: 11232200
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
    Arroyo V, Jiménez W.
    J Hepatol; 2000 May; 32(1 Suppl):157-70. PubMed ID: 10728802
    [Abstract] [Full Text] [Related]

  • 8. [Pathogenesis of sodium and water retention in cirrhosis of the liver].
    Martin PY.
    Praxis (Bern 1994); 1997 Jul 30; 86(31-32):1194-7. PubMed ID: 9340706
    [Abstract] [Full Text] [Related]

  • 9. Physiopathology of ascites in portal hypertension.
    Michielsen PP.
    Acta Gastroenterol Belg; 1996 Jul 30; 59(3):191-7. PubMed ID: 9015930
    [Abstract] [Full Text] [Related]

  • 10. Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.
    Bolognesi M, Di Pascoli M, Verardo A, Gatta A.
    World J Gastroenterol; 2014 Mar 14; 20(10):2555-63. PubMed ID: 24627591
    [Abstract] [Full Text] [Related]

  • 11. Pathogenesis and treatment of fluid and electrolyte imbalance in cirrhosis.
    Cárdenas A, Ginès P.
    Semin Nephrol; 2001 May 14; 21(3):308-16. PubMed ID: 11320500
    [Abstract] [Full Text] [Related]

  • 12. Ascites in liver diseases.
    Gentilini P, Laffi G.
    Ann Ital Med Int; 1991 May 14; 6(1 Pt 2):148-55. PubMed ID: 1742150
    [Abstract] [Full Text] [Related]

  • 13. Pathophysiology and treatment of ascites and the hepatorenal syndrome.
    Gentilini P, Laffi G.
    Baillieres Clin Gastroenterol; 1992 Sep 14; 6(3):581-607. PubMed ID: 1421601
    [Abstract] [Full Text] [Related]

  • 14. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A, Landaverde C, Medici V, Rossaro L.
    QJM; 2008 Feb 14; 101(2):71-85. PubMed ID: 18184668
    [Abstract] [Full Text] [Related]

  • 15. Pathogenesis of ascites and predictors of resistance to therapy.
    De Franchis R, Salerno F.
    J Gastroenterol Hepatol; 2002 Dec 14; 17 Suppl 3():S242-7. PubMed ID: 12472943
    [Abstract] [Full Text] [Related]

  • 16. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
    Arroyo V.
    Ann Hepatol; 2002 Dec 14; 1(2):72-9. PubMed ID: 15115971
    [Abstract] [Full Text] [Related]

  • 17. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.
    Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J.
    Hepatology; 1988 Dec 14; 8(5):1151-7. PubMed ID: 2971015
    [Abstract] [Full Text] [Related]

  • 18. Vasopressin 1a receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats.
    Fernández-Varo G, Oró D, Cable EE, Reichenbach V, Carvajal S, de la Presa BG, Wiśniewski K, Ginés P, Harris G, Jiménez W.
    Hepatology; 2016 Jan 14; 63(1):207-16. PubMed ID: 26403564
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.